1. Home
  2. SPRC vs PTIX Comparison

SPRC vs PTIX Comparison

Compare SPRC & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRC
  • PTIX
  • Stock Information
  • Founded
  • SPRC 2004
  • PTIX 1994
  • Country
  • SPRC Israel
  • PTIX United States
  • Employees
  • SPRC N/A
  • PTIX N/A
  • Industry
  • SPRC Biotechnology: Pharmaceutical Preparations
  • PTIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPRC Health Care
  • PTIX Health Care
  • Exchange
  • SPRC Nasdaq
  • PTIX Nasdaq
  • Market Cap
  • SPRC 3.4M
  • PTIX 2.9M
  • IPO Year
  • SPRC N/A
  • PTIX 2016
  • Fundamental
  • Price
  • SPRC $7.95
  • PTIX $3.42
  • Analyst Decision
  • SPRC
  • PTIX
  • Analyst Count
  • SPRC 0
  • PTIX 0
  • Target Price
  • SPRC N/A
  • PTIX N/A
  • AVG Volume (30 Days)
  • SPRC 29.6K
  • PTIX 196.0K
  • Earning Date
  • SPRC 02-15-2025
  • PTIX 08-13-2025
  • Dividend Yield
  • SPRC N/A
  • PTIX N/A
  • EPS Growth
  • SPRC N/A
  • PTIX N/A
  • EPS
  • SPRC N/A
  • PTIX N/A
  • Revenue
  • SPRC $1,306,000.00
  • PTIX N/A
  • Revenue This Year
  • SPRC N/A
  • PTIX N/A
  • Revenue Next Year
  • SPRC N/A
  • PTIX N/A
  • P/E Ratio
  • SPRC N/A
  • PTIX N/A
  • Revenue Growth
  • SPRC N/A
  • PTIX N/A
  • 52 Week Low
  • SPRC $4.14
  • PTIX $2.35
  • 52 Week High
  • SPRC $37.59
  • PTIX $15.54
  • Technical
  • Relative Strength Index (RSI)
  • SPRC 58.06
  • PTIX 45.21
  • Support Level
  • SPRC $6.25
  • PTIX $3.33
  • Resistance Level
  • SPRC $8.50
  • PTIX $3.58
  • Average True Range (ATR)
  • SPRC 0.66
  • PTIX 0.24
  • MACD
  • SPRC 0.12
  • PTIX 0.00
  • Stochastic Oscillator
  • SPRC 58.54
  • PTIX 18.42

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

Share on Social Networks: